Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
RPRX Insider Trading and Fund Holdings (Royalty Pharma plc) · https://wallstpal.com/stock/rprx/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 1802768

Royalty Pharma plc (RPRX): Insider Trades and Fund Holdings

In the past 12 months, Royalty Pharma plc insiders reported no open-market purchases and 10 sales worth $29.5M; 10 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months
$0Bought by insiders, 12 months
$29.5MSold by insiders, 12 months
2Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Oct 5, 2026Insider saleEVP Marshall Urist sold $235,595 under a 10b5-1 plan
  2. Oct 5, 2026Planned saleUrist Marshall (officer) filed notice to sell about $235,595 around Oct 5, 2026
  3. Sep 28, 2026Insider saleEVP Marshall Urist sold $238,813 under a 10b5-1 plan
  4. Sep 28, 2026Planned saleUrist Marshall (officer) filed notice to sell about $238,813 around Sep 28, 2026
  5. Sep 22, 2026Insider saleChair Christopher Hite sold $5.9 million under a 10b5-1 plan
  6. Sep 22, 2026Planned saleSCH Investment Partners LLC (officer) filed notice to sell about $5.8 million around Sep 22, 2026
  7. Aug 18, 2026Insider saleChair Christopher Hite sold $6 million under a 10b5-1 plan
  8. Aug 18, 2026Planned saleSCH Investment Partners LLC (officer) filed notice to sell about $6 million around Aug 18, 2026
  9. Aug 13, 2026Insider saleCFO Terrance P. Coyne sold $645,551 under a 10b5-1 plan
  10. Jul 1, 2026Insider saleEVP Marshall Urist sold $508,454 under a 10b5-1 plan
  11. Jun 30, 2026Insider saleChair Christopher Hite sold $7.3 million under a 10b5-1 plan
  12. Jun 30, 2026FundBridgewater Associates opened a position in Q2 2026 (13F filed Aug 14, 2026)
  13. Jun 30, 2026FundRenaissance Technologies added 145% in Q2 2026 (13F filed Aug 13, 2026)
  14. Jun 24, 2026Insider saleEVP Marshall Urist sold $502,067 under a 10b5-1 plan
  15. Jun 23, 2026Insider saleChair Christopher Hite sold $8.2 million under a 10b5-1 plan

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 5, 2026.

Recent RPRX insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueHoldingFiling
Oct 5Oct 5Marshall UristEVPEVP▼ SELL10b5-14,12657.10$236KAll soldForm 4 ↗
Sep 30Sep 28Marshall UristEVPEVP▼ SELL10b5-14,12657.88$239K−50%Form 4 ↗
Sep 24Sep 22Christopher HiteChairChair (ind.)▼ SELL10b5-1100,00058.53$5.85M−27%Form 4 ↗
Aug 19Aug 18Christopher HiteChairChair (ind.)▼ SELL10b5-1100,00059.97$6.00M−21%Form 4 ↗
Aug 17Aug 13Terrance P. CoyneCFOCFO (ind.)▼ SELL10b5-111,00258.68$646KAll soldForm 4 ↗
Jul 2Jun 30Christopher HiteChairChair (ind.)▼ SELL10b5-1100,00056.52$5.65M−18%Form 4 ↗
Jul 2Jun 30Christopher HiteChairChair▼ SELL10b5-130,00056.46$1.69M−43%Form 4 ↗
Jul 2Jul 1Marshall UristEVPEVP▼ SELL10b5-19,09955.88$508KAll soldForm 4 ↗
Jun 25Jun 23Christopher HiteChairChair (ind.)▼ SELL10b5-1150,00054.40$8.16M−21%Form 4 ↗
Jun 25Jun 24Marshall UristEVPEVP▼ SELL10b5-19,09855.18$502K−50%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Marshall UristEVP0$04$1.48MOct 5, 2026
Christopher HiteChair0$05$27.4MSep 24, 2026
Terrance P. CoyneCFO0$01$646KAug 17, 2026

Buybacks and executive pay

Royalty Pharma plc spent $1.23 billion buying back its own shares in 2025.

YearCEO pay reportedCEO pay "actually paid"Value of $100 invested
2025$938K$82.5Mn/a
2024n/a$191.3Mn/a
2023n/a$26.8Mn/a

From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.

Filing quality

A All 10 insider trades reported on time. How it is graded

Tracked funds that report RPRX

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Renaissance TechnologiesQ2 20261,935,800$108.5M0.15%▲ +144.7%
Bridgewater AssociatesQ2 2026219,687$12.3M0.05%▲ New
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →